Viewing StudyNCT00273936



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00273936
Status: COMPLETED
Last Update Posted: 2011-08-04
First Post: 2006-01-06

Brief Title: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Sponsor: Vertex Pharmaceuticals Incorporated
Organization: Vertex Pharmaceuticals Incorporated

Conditions & Keywords Data

Conditions:
Name
Waldenstroms Macroglobulinemia
Acute Leukemia
Chronic Leukemia
Multiple Myeloma
Hodgkins Lymphoma
Non-Hodgkins Lymphoma
Keywords: